Quantcast

Monthly Archives: December 2011

Are Homebuilders, Home Improvement Stores Coming Back? (NVR, TOL, PHM, HOV, DHI, BZH, HD, LOW)

Stocks in homebuilders have been down so low for so long that almost anything look like up. Recent earnings releases have indicated that new orders are improving, but much of ...
Read Full Story »

J.C. Penney’s Ron Johnson Transformation… With Martha Stewart (JCP, MSO, AAPL, M, SHLD, HD)

J. C. Penney Company, Inc. (NYSE: JCP) is a company which many investors and outsiders expect to be in a transformation.  The first such addition under new management is a ...
Read Full Story »

Airline Profit Forecast Cut in Half for 2012 (DAL, UAL, LUV, LCC)

Cost increases and flat cargo traffic are expected to cut airline profits in half in 2012, from $6.9 billion in 2011 to $3.5 billion in 2012. Profit margin is expected ...
Read Full Story »

Top Analyst Upgrades & Downgrades (ALL, AMZN, BX, CTL, CB, DRI, FSL, GEOI, GOOG, JDSU, LNKD, BTU, PEG, DGX, TLB, TRV, UIS, UNH, URBN, WSH)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Allstate Corporation (NYSE: ALL) Started as Outperform at Credit Suisse. ...
Read Full Story »

The Biggest Corporate Layoffs of All Time

Eleven American companies have laid off a total of nearly 600,000 people in the past two decades. Each also fired a large number of employees at one time to earn ...
Read Full Story »

Fashion and Financial Failures at Chico’s

Chico’s FAS (NYSE: CHS) said its growth story remains intact, even though consumer spending is expected to remain soft. Additionally, despite falling margins at its flagship stores and rising inventories, ...
Read Full Story »

Home Price Improvement Is Geographically Diverse

The housing crisis has been the worse in five states -- Nevada, California, Florida, Michigan and Arizona. A recovery has begun in states that have almost nothing in common geographically ...
Read Full Story »

Job Creation Falters

There has been plenty of evidence in the past month that job creation is the U.S. has restarted for the first time since the 2007 to 2009 recession. Now, it ...
Read Full Story »

Media Digest (12/7/2011) Reuters, WSJ, NYTime, FT, Bloomberg

The board of Olympus may resign by late February. (Reuters) China says its annual rate of growth slowed between October and November. (Reuters) Congress pressures the CFTC for stronger regulation ...
Read Full Story »

Bank of America Improves — Compared to What?

Bank of America (NYSE: BAC) CEO Brian Moynihan has no credibility left on Wall St. That makes his comments that the financial firm’s balance sheet has improved hard to believe. Skepticism ...
Read Full Story »

What’s Important in the Financial World (12/7/2011) Citigroup Job Cuts, China’s Economy Slows

A New Bailout Fund. Rumors suggest that leading eurozone nations, particularly France and Germany, may have begun the process to create a large bailout fund for the financially weak nations in ...
Read Full Story »

Citigroup (C) Fires 4,500

According to media reports, Citigroup (NYSE: C) will fire 4,500 people MarketWatch reports The bank will make the cuts which are less than 2% of its workforce, in an effort ...
Read Full Story »

24/7 Wall St. Closing Bell (MO, VZ, TSO, LNKD, GE, CHKR, BTH, PBY, UEC, AZO, DRI, TOL, LQDT, DMND, SAI, VRA, FRO, CTIC, CRK, VG, HL)

Equities opened a little weaker this morning, but by 10:00 a.m. markets had turned slightly positive and have remained in positive territory for the rest of the day. The gain ...
Read Full Story »

Expected Gains in For-Profit College Stocks (APOL, WPO, STRA, DV, CECO)

After a shaky start to the year, the for-profit college sector has pulled itself back up. With one exception, however, four of five stocks we looked at are still down ...
Read Full Story »

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

Dendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment.  Unfortunately, PROVENGE sales ran slower than expected after the FDA took forever to ...
Read Full Story »